Introduction

The Department of Oncology and Hematology treats various types of tumors (from examination for treatment plan after diagnosis to establishment of treatment plan, collaboration with the relevant department, chemotherapy and follow-up examination after treatment), and diagnoses and treats various blood diseases.

Main diseases include anemia, hemorrhagic disease (thrombocytopenia, hemophilia, etc.), leukocyte abnormality, malignant lymphoma, acute or chronic leukemia, chronic myeloproliferative disease, solid cancer (gastric cancer, lung cancer, breast cancer, colorectal cancer, rectal cancer, ovarian cancer, head and neck cancer) , esophageal cancer, osteosarcoma, sarcoma, and many other cancers).

The Department of Oncology and Hematology provides customized treatment based on the latest medical technology for these malignant diseases, taking into account the type, progress of the cancer, and the patient's condition. Proceed.
In particular, the proper use of anticancer drugs is of utmost importance in the treatment of tumors. This is because, in the course of treatment, the dosage must vary depending on the response and side effects to anticancer drugs.

The Department of Oncology and Hematology provides treatment by disease-specific treatment such as allogeneic or autologous hematopoietic stem cell transplantation (bone marrow transplantation) for blood diseases or blood cancer, while concurrently administering symptom relief treatment for cancer patients with the use of anticancer drugs with proven safety and effectiveness. By differentiated methods, we strive to support patients' treatment and improve their quality of life.

Medical Fields